Overview
ABeta amyloidosis, Italian type, is an extremely rare inherited condition caused by a specific mutation in the APP gene, which provides instructions for making amyloid precursor protein. This mutation leads to the abnormal buildup of a protein called amyloid-beta in the walls of blood vessels in the brain, a condition known as cerebral amyloid angiopathy (CAA). Over time, this protein deposit weakens blood vessel walls, making them fragile and prone to bleeding. The disease primarily affects the brain and its blood vessels. People with this condition typically develop symptoms in adulthood, often including recurrent strokes caused by bleeding in the brain (hemorrhagic strokes), progressive cognitive decline or dementia, and sometimes seizures. Headaches and neurological problems such as weakness or difficulty speaking may also occur, especially during or after a bleeding episode. There is currently no cure for ABeta amyloidosis, Italian type. Treatment focuses on managing symptoms, preventing further bleeding events, and providing supportive care. Blood pressure control is important to reduce the risk of hemorrhagic strokes. Rehabilitation services, including physical therapy, occupational therapy, and speech therapy, may be needed after stroke events. The disease was originally identified in families of Italian descent, which is how it received its name.
Also known as:
Key symptoms:
Recurrent strokes caused by brain bleedingProgressive memory loss and dementiaSeizuresSevere headachesWeakness on one side of the bodyDifficulty speaking or understanding speechVision changesConfusion or disorientationPersonality or behavior changesDifficulty with balance and coordinationCognitive decline over time
Clinical phenotype terms (7)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for ABeta amyloidosis, Italian type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for ABeta amyloidosis, Italian type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for ABeta amyloidosis, Italian type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to ABeta amyloidosis, Italian type.
Community
No community posts yet. Be the first to share your experience with ABeta amyloidosis, Italian type.
Start the conversation →Latest news about ABeta amyloidosis, Italian type
No recent news articles for ABeta amyloidosis, Italian type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific APP gene mutation do I have, and what does it mean for my prognosis?,Should my family members be tested for this genetic mutation?,What medications should I avoid because they could increase my risk of brain bleeding?,What is my target blood pressure, and how should I monitor it at home?,What are the warning signs of a new brain bleed, and when should I go to the emergency room?,Are there any clinical trials or experimental treatments I might be eligible for?,What rehabilitation or support services are available to help me maintain my independence?
Common questions about ABeta amyloidosis, Italian type
What is ABeta amyloidosis, Italian type?
ABeta amyloidosis, Italian type, is an extremely rare inherited condition caused by a specific mutation in the APP gene, which provides instructions for making amyloid precursor protein. This mutation leads to the abnormal buildup of a protein called amyloid-beta in the walls of blood vessels in the brain, a condition known as cerebral amyloid angiopathy (CAA). Over time, this protein deposit weakens blood vessel walls, making them fragile and prone to bleeding. The disease primarily affects the brain and its blood vessels. People with this condition typically develop symptoms in adulthood, o
How is ABeta amyloidosis, Italian type inherited?
ABeta amyloidosis, Italian type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does ABeta amyloidosis, Italian type typically begin?
Typical onset of ABeta amyloidosis, Italian type is adult. Age of onset can vary across affected individuals.